Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion type Assertion NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_head.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion description "[Furthermore, identification of rare loss-of-function variants in genes such as PCSK9, NPC1L1, APOC3 and APOA5, which cause a markedly decreased risk of CHD and no adverse side effects, illustrates the power of translating genetic findings into novel mechanistic information and provides some optimism for the future of developing novel drugs, given the many genes associated with CHD in GWASs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_provenance.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion evidence source_evidence_literature NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_provenance.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion SIO_000772 26477595 NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_provenance.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion wasDerivedFrom befree-2016 NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_provenance.
- NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_assertion wasGeneratedBy ECO_0000203 NP1295039.RAwEXqGgVSgJUR4RHXOKFpCQ6tpOZh2eam4fVdjynN3aY130_provenance.